Ningbo Home Test Biotechnology Co., Ltd. is mainly engaged in the research and development, production and sales of medical devices and in vitro diagnostic reagents. It mainly involves IVD products such as physical examination, diagnosis, reproduction, family medicine, gynecological examination, infectious disease detection, tumor detection and medical analysis.
The diagnosis now covers 29 finished items, such as early pregnancy, ovulation, infectious diseases, sexually transmitted diseases, AIDS and gynecological diseases. Home medications include blood pressure, blood sugar, blood lipid testing, cooling patches and warm patches; gynecological examinations include bacterial vaginitis testing equipment and supplies.
At the same time, it provides raw materials for foreign customers, including: reproductive raw materials, infectious disease and tumor marker raw materials and other raw materials.
By fully understanding the market needs and local market rules of each country, finished products have been registered in America, Europe, Africa, Southeast Asia (including Myanmar, Thailand, Laos and Vietnam), and Brazil. The raw materials, including uncut sheets, have been sold to Russia, Canada, Iran, Saudi Arabia, India, South Korea and the Middle East.
Ningbo Home Test Biotechnology Co., Ltd. promotes lean production, fine management and meticulous service, and promotes leading standards, quality revolution and brand building. Brands with suitable varieties, high quality and good reputation have advantages in the market and have industry standards. Companies adhere to innovation-driven, focus on cultivating and developing strategic emerging industries, transform and upgrade traditional industries, carry out technological innovation, management innovation and business model innovation, cultivate new growth points, and form new competitive advantages.